PCSK9 regulates pyroptosis via mtDNA damage in chronic myocardial ischemia
暂无分享,去创建一个
Jinghang Zhang | Xianwei Wang | Zufeng Ding | Shijie Liu | Xiao Li | Sichang Zhou | Anna Brickell | Zekun Wu
[1] J. Mehta,et al. NLRP3 inflammasome via IL-1β regulates PCSK9 secretion , 2020, Theranostics.
[2] G. Dubyak,et al. N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis , 2020, Nature Communications.
[3] Jia Hu,et al. NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy , 2020, Redox biology.
[4] A. Poltorak,et al. cFLIPL protects macrophages from LPS-induced pyroptosis via inhibition of complex II formation , 2020, Science.
[5] J. Lupón,et al. Role of PCSK9 in the course of ejection fraction change after ST‐segment elevation myocardial infarction: a pilot study , 2020, ESC heart failure.
[6] S. Saito,et al. Pyroptosis is a critical inflammatory pathway in the placenta from early onset preeclampsia and in human trophoblasts exposed to hypoxia and endoplasmic reticulum stressors , 2019, Cell Death & Disease.
[7] J. Mehta,et al. Blood flow patterns regulate PCSK9 secretion via MyD88 mediated proinflammatory cytokines. , 2019, Cardiovascular research.
[8] A. Gotto,et al. PCSK9 and inflammation: a review of experimental and clinical evidence. , 2019, European heart journal. Cardiovascular pharmacotherapy.
[9] N. Chattipakorn,et al. PCSK9 inhibitor improves cardiac function and reduces infarct size in rats with ischaemia/reperfusion injury: Benefits beyond lipid‐lowering effects , 2019, Journal of cellular and molecular medicine.
[10] Masafumi Takahashi. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction. , 2019, Journal of cardiovascular pharmacology.
[11] Z. Xia,et al. Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome , 2019, Cell Death & Disease.
[12] F. Shao,et al. Innate immunity to intracellular LPS , 2019, Nature Immunology.
[13] Zan Huang,et al. Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation , 2019, Journal of molecular cell biology.
[14] J. Mehta,et al. PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy , 2018, Cardiovascular research.
[15] J. Mehta,et al. PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages , 2018, Cardiovascular research.
[16] J. Mehta,et al. Inflammation, Autophagy, and Apoptosis After Myocardial Infarction , 2018, Journal of the American Heart Association.
[17] M. Adorni,et al. PCSK9 induces a pro-inflammatory response in macrophages , 2018, Scientific Reports.
[18] R. Schulz,et al. Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way , 2017, Basic Research in Cardiology.
[19] Si Ming Man,et al. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases , 2017, Immunological reviews.
[20] J. Mehta,et al. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases , 2017, Basic Research in Cardiology.
[21] J. Mehta,et al. Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis. , 2016, Antioxidants & redox signaling.
[22] A. Sahebkar,et al. Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms. , 2016, British journal of clinical pharmacology.
[23] Patrick W Serruys,et al. PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study. , 2016, Atherosclerosis.
[24] Lesley Burgess,et al. PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.
[25] A. Quyyumi,et al. Plasma PCSK9 Levels Are Elevated with Acute Myocardial Infarction in Two Independent Retrospective Angiographic Studies , 2014, PloS one.
[26] A. Wree,et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice , 2014, Hepatology.
[27] D. Yellon,et al. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.
[28] J. Mehta,et al. Abrogation of lectin-like oxidized LDL receptor-1 attenuates acute myocardial ischemia-induced renal dysfunction by modulating systemic and local inflammation. , 2012, Kidney international.
[29] O. Palyha,et al. Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9. , 2012, Journal of the American College of Cardiology.
[30] E. Fisher,et al. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] Lawrence Buja,et al. Modes of myocardial cell injury and cell death in ischemic heart disease. , 1998, Circulation.
[32] M. Rekhter,et al. Graft permeabilization facilitates gene therapy of transplant arteriosclerosis in a rabbit model. , 1998, Circulation.